Related references
Note: Only part of the references are listed.Involvement of functional autoantibodies against vascular receptors in systemic sclerosis
Gabriela Riemekasten et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension
Aranzazu Campo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 (ALK1) Mutation
Barbara Girerd et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
Hossein A. Ghofrani et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group
Jerome Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Anti-endothelial cell antibodies in systemic sclerosis
C. Mihai et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population
P. Dieude et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The Transcription Factor Fra-2 Regulates the Production of Extracellular Matrix in Systemic Sclerosis
Nicole Reich et al.
ARTHRITIS AND RHEUMATISM (2010)
Pulmonary Arterial Hypertension Baseline Characteristics From the REVEAL Registry
David B. Badesch et al.
CHEST (2010)
Cardiac complications of systemic sclerosis: recent progress in diagnosis
Adel Boueiz et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
S. C. Mathai et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians
P. Mangat et al.
INTERNAL MEDICINE JOURNAL (2010)
Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies
Jerome Avouac et al.
JOURNAL OF RHEUMATOLOGY (2010)
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension A Randomized Controlled Clinical Trial
Vallerie V. McLaughlin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: An experience-based review
Ronald J. Oudiz et al.
AMERICAN HEART JOURNAL (2009)
Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma
Edoardo Savarino et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Connective Tissue Disease-associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Robin Condliffe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Survival in Pulmonary Hypertension Associated With the Scleroderma Spectrum of Diseases Impact of Interstitial Lung Disease
Stephen C. Mathai et al.
ARTHRITIS AND RHEUMATISM (2009)
Mechanisms of vascular damage in systemic sclerosis
Ulf Mueller-Ladner et al.
AUTOIMMUNITY (2009)
Estimating a Minimally Important Difference in Pulmonary Arterial Hypertension Following Treatment With Sildenafil
Claire Gilbert et al.
CHEST (2009)
Tadalafil Therapy for Pulmonary Arterial Hypertension
Nazzareno Galie et al.
CIRCULATION (2009)
Transcription Factor Fos-Related Antigen-2 Induces Progressive Peripheral Vasculopathy in Mice Closely Resembling Human Systemic Sclerosis
Britta Maurer et al.
CIRCULATION (2009)
Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension
Henrik ten Freyhaus et al.
CLINICAL RESEARCH IN CARDIOLOGY (2009)
Therapy for pulmonary arterial hypertension associated with systemic sclerosis
Stephen C. Mathai et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
M. J. Overbeek et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Autoantigens in systemic autoimmunity: critical partner in pathogenesis
A. Rosen et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Limitations to the 6-Minute Walk Test in Interstitial Lung Disease and Pulmonary Hypertension in Scleroderma
Margaret C. Garin et al.
JOURNAL OF RHEUMATOLOGY (2009)
Abnormalities in the Regulators of Angiogenesis in Patients with Scleroderma
Laura K. Hummers et al.
JOURNAL OF RHEUMATOLOGY (2009)
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association
Vallerie V. McLaughlin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Therapies for scleroderma-related pulmonary arterial hypertension
Paul M Hassoun
Expert Review of Respiratory Medicine (2009)
Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension
Benjamin Terrier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension
Paul R. Forfia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials
J. Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: A Delphi consensus study with cluster analysis
Oliver Distler et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension
Xavier Jais et al.
ARTHRITIS AND RHEUMATISM (2008)
Possible role of imatinib in clinical pulmonary veno-occlusive disease
M. J. Overbeek et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension
M. J. Overbeek et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
The many faces of scleroderma
Virginia D. Steen
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2008)
Incidence and prevalence of systemic sclerosis: A systematic literature review
Helene Chifflot et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2008)
Identification of candidate genes in scleroderma-related pulmonary arterial hypertension
Dmitry N. Grigoryev et al.
TRANSLATIONAL RESEARCH (2008)
Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases
C. P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis
Y. Allanore et al.
ARTHRITIS AND RHEUMATISM (2008)
Selective endothelinA receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease
Reda E. Girgis et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases
Peter Dorfmueller et al.
HUMAN PATHOLOGY (2007)
Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension
J. Wipff et al.
RHEUMATOLOGY (2007)
Pulmonary involvement in systemic sclerosis: Associations with genetic, serologic, sociodemographic, and behavioral factors
Terry A. McNearney et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Genetics and mediators in pulmonary arterial hypertension
Eric D. Austin et al.
CLINICS IN CHEST MEDICINE (2007)
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension
S. C. Mathai et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension
Lionel Schachna et al.
ARTHRITIS AND RHEUMATISM (2006)
Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review
S. R. Johnson et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Tricuspid annular displacement predicts survival in pulmonary hypertension
Paul R. Forfia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension
M. C. Tamby et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Clinical differences between idiopathic and scleroderma-related pulmonary hypertension
Micah R. Fisher et al.
ARTHRITIS AND RHEUMATISM (2006)
Long term imatinib treatment in pulmonary arterial hypertension
R. Souza et al.
THORAX (2006)
Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension
Karen C. Patterson et al.
ANNALS OF INTERNAL MEDICINE (2006)
Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension
Olivier Sanchez et al.
CHEST (2006)
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
Mark H. Williams et al.
EUROPEAN HEART JOURNAL (2006)
Pulmonary arterial hypertension in France - Results from a national registry
M Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
Anna Fijalkowska et al.
CHEST (2006)
Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
S Provencher et al.
EUROPEAN HEART JOURNAL (2006)
Autoimmunity and pulmonary hypertension: a perspective
MR Nicolls et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Early detection of pulmonary arterial hypertension in systemic sclerosis -: A French nationwide prospective multicenter study
E Hachulla et al.
ARTHRITIS AND RHEUMATISM (2005)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases
RE Girgis et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Imatinib for the treatment of pulmonary arterial hypertension
HA Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Ambrisentan therapy for pulmonary arterial hypertension
N Galié et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Risk of malignancy in scleroderma - A population-based cohort study
S Chatterjee et al.
ARTHRITIS AND RHEUMATISM (2005)
The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study)
FM Wigley et al.
ARTHRITIS AND RHEUMATISM (2005)
Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension
GA Paul et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
O Sitbon et al.
CIRCULATION (2005)
The right ventricle in pulmonary hypertension
KM Chin et al.
CORONARY ARTERY DISEASE (2005)
Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension
MC Tamby et al.
THORAX (2005)
A study of the prevalence of systemic sclerosis in northeast England
RJ Allcock et al.
RHEUMATOLOGY (2004)
Sitaxsentan therapy for pulmonary arterial hypertension
RJ Barst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Prevalence of systemic sclerosis in a French multi-ethnic county
V Le Guern et al.
RHEUMATOLOGY (2004)
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease
RJ Oudiz et al.
CHEST (2004)
Prognosis of pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
VV McLaughlin et al.
CHEST (2004)
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population
MD Mayes et al.
ARTHRITIS AND RHEUMATISM (2003)
Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies
C Feghali-Bostwick et al.
ARTHRITIS AND RHEUMATISM (2003)
Systemic sclerosis: the susceptible host (genetics and environment)
FK Tan
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)
Scleroderma epidemiology
MD Mayes
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis
MM Cerinic et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2003)
Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement
V Steen et al.
ARTHRITIS AND RHEUMATISM (2003)
Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis
SM Kawut et al.
CHEST (2003)
Age and risk of pulmonary arterial hypertension in scleroderma
L Schachna et al.
CHEST (2003)
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
D Mukerjee et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases
MB Tew et al.
ARTHRITIS AND RHEUMATISM (2002)
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension -: Prognostic factors and survival
O Sitbon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension - A double-blind, randomized, placebo-controlled trial
G Simonneau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers
O Distler et al.
ARTHRITIS RESEARCH (2002)
Nonspecific interstitial pneumonia and usual interstitial pneumonia: Comparative appearances at and diagnostic accuracy of thin-section CT
SLS MacDonald et al.
RADIOLOGY (2001)
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
RC Trembath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Systemic sclerosis: environmental and occupational risk factors
PJ Nietert et al.
CURRENT OPINION IN RHEUMATOLOGY (2000)
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
DB Badesch et al.
ANNALS OF INTERNAL MEDICINE (2000)
Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension - Comparison with cardiopulmonary exercise testing
S Miyamoto et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
